Everybody’s Got A Story……….. Text tells “the story” in readable language that supports the coding Accurate, concise summary of the patient’s cancer.

Slides:



Advertisements
Similar presentations
Cancer Registry Follow-up How we do it
Advertisements

Instructions and Reporting Requirements Module 3 Electronic Reporting For Facilities March 2014 North Carolina Central Cancer Registry State Center for.
Instructions and Reporting Requirements Module 2 Electronic Reporting For Facilities March 2014 North Carolina Central Cancer Registry State Center for.
Nadya Dimitrova Marieta Petkova. 13 Regional cancer registries BNCR: -Established in 1952; cases a year; million population;
© 2012 Cengage Learning. All Rights Reserved. May not be scanned, copied, duplicated, or posted to a publicly accessible website, in whole or in part.
15 The Health Record.
Cancer Registry Coding Changes for 2014 Presented by the Kentucky Cancer Registry February, 2014.
Inpatient Coding Strategies American College of Physicians March 1, 2013.
McKesson Upgrade - ER 11/12 What is ER 11/12? ER is “Enterprise Release” and 11/12 is the software version. This release will upgrade many parts of the.
Cancer Staging. What is cancer staging? Staging describes the severity of a person’s cancer based on the extent of the original (primary) tumor and whether.
Mississippi Cancer Registry Deirdre B. Rogers, MS Director Mississippi Cancer Registry.
TRAM Educational Conference September 19, 2014 Meritus Medical Center 1.
© 2013 The McGraw-Hill Companies, Inc. All rights reserved. Chapter 9 Tests, Procedures, and Codes.
Unit 4: Monitoring Data Quality For HIV Case Surveillance Systems #6-0-1.
Medical Reports Dr. Nasser Al - Jarallah.
Medication History: Keeping our patients safe. How do we get all of the correct details?
TS16949 requirements Subjects –Audit planning –Recertification audit requirements –Auditing Remote supporting functions.
Communication is Vital! Technology is your friend!
Quality Cancer Data The Vital Role of Cancer Registrars in the Fight against Cancer Saves Lives.
Meaningful Use Measures. Reporting Time Periods Reporting Period for 1 st year of MU (Stage 1) 90 consecutive days within the calendar year Reporting.
Instructions and Reporting Requirements Appendix B Electronic Reporting For Dermatology Physician Practices March 2014 North Carolina Central Cancer Registry.
Copyright ©2011 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved. Pearson's Comprehensive Medical Assisting: Administrative.
1 MP/H Coding Rules General Instructions MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
Instructions and Reporting Requirements Appendix B Electronic Reporting For Facilities March 2014 North Carolina Central Cancer Registry State Center.
Casefinding & Follow-Up Dolores E. McCord, RHIT, CTR Piedmont Hospital Atlanta, Georgia.
Cancer Staging.
Putting the Puzzle Together: Breast Collaborative Staging Melissa Riddle, RHIT, CTR October 6, 2012.
Hospital maintain various indexes and register so that each health records and other health information can be located and classified for Patient care.
Coding Compliance Plan July 12, Benefits of a compliance program  To demonstrate our commitment to honest and responsible conduct, decrease the.
Timeliness of Cancer Registry Reporting Ali Johnson, CTR Vermont Cancer Registry Vermont Explor Annual Data Meeting May 1, 2006.
1 Myeloma Plasma Cell Disorders (Schema Name: MyelomaPlasmaCellDisorder) V0203.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
CASEFINDING Debra W. Christie, MBA, RHIA, CTR, CCRP Director, Cancer Research & Data Center University of Mississippi Medical Center.
Copyright © 2009 by The McGraw-Hill Companies, Inc. All Rights Reserved. McGraw-Hill Chapter 7 Introduction to Practice Partner Electronic Health Records.
2015 CHANGES IN REPORTING REQUIREMENTS AND CANCER CODING INSTRUCTIONS KENTUCKY CANCER REGISTRY SPRING TRAINING 2015 PRESENTED BY FRANCES ROSS.
BNR – Stroke: data entry and data management CAREC/PAHO Curacoa,15-16 November 2010 Gina Pitts, BNR-CVD Registrar Chronic Disease Research Centre, Jemmotts.
Define: charting diagnosis discharge summary report electronic medical record health history report Informed consent medical record medical record format.
Data Sources-Cancer Betsy A. Kohler, MPH, CTR Director, Cancer Epidemiology Services New Jersey Department of Health and Senior Services.
An Integrated Approach to Breast Cancer Control A flexible approach that can be adapted to national or local circumstances.
School of Health Sciences Week 4! AHIMA Practice Brief Fundamentals of Health Information HI 140 Instructor: Alisa Hayes, MSA, RHIA, CCRC.
Acknowledgements This report differs from the submitted abstract due to further subdivision of patients into analytic and non- analytic, and focus on the.
New Data Items MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Pathology.
Collaborative Staging for Colon Site Specific Factors Tonya Brandenburg, MHA, CTR QA Manager Abstracting and Coding Kentucky Cancer Registry.
Vicki LaRue, CTR KCR Abstractor’s Training February 12,
*Be brief, yet thorough enough to allow recoding of the data fields from the text only! * Use accepted abbreviations from Abstractor’s Manual Appendix.
SECTION I ACTIVE DIAGNOSES January 14, PM.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
BY FRANCES ROSS, CTR PRESENTED AT THE NAACCR ANNUAL CONFERENCE JUNE, 2008 Record Consolidation Test with the 2007 Multiple Primary/Histology Rules.
Integrating Central and Hospital Registries To Improve Timeliness and Data Quality (The Central Cancer Registry as a Hub for Data Exchange) David Rousseau,
Is Your Data Management System Flexible for Quality Control Activities? Winny Roshala, CTR Data Standards and Quality Control Unit NAACCR: June 13-19,
Treatment Capture from Follow Back to Oncology Offices by Frances Ross Presented at the 2013 NAACCR Annual Conference Austin, TX.
Medical Documentation CHAPTER 17. Purposes of Documentation  Communication  Most patients receive care from more than one source  Allows all health.
Clinical Aspect Medical Office Assisting State the need for a health history. State the need for a health history. Describe the components of the health.
The Role of the HCC Cancer Registry in Facilitating Cancer Research Linda Cope, CTR HCC Registry Coordinator
2016 Edits.
Documentation and Medical Records
TEXT, FOLLOW –UP AND THE CANCER REGISTRAR
Creating the perfect text…
Patient Medical Records
What’s New for 8th Edition
Cancer Staging.
Managing Medical Records Lesson 1:
Cancer 101: A Cancer Education and Training Program for [Target Population] Date Location Presented by: Presenter 1 Presenter 2 1.
The Progress of npcr audits What have we done, what have we learned, and where are we going now Click to edit subtitle Click to enter your Division Name.
Text Mining for Data Quality Analysis of Melanoma Tumor Depth
Presentation transcript:

Everybody’s Got A Story……….. Text tells “the story” in readable language that supports the coding Accurate, concise summary of the patient’s cancer

Text Uses…… Support coding Support unusual site/histology combos Explain unusual abstract entries Document ambiguous terminology Document additional info or questions

And Even More Text Uses Support accuracy and validity of data Eliminate the need to pull charts again Edit check verification Re-coding/re-staging of historical data Researcher/facility use

Text Uses At Central Registry Validate codes in the abstract – Sequence – Extent – Treatment Reconcile codes and consolidate abstracts from different facilities QC audits

Critical Data Items Age ** DOB Sex Race Sequence number Stage Date of diagnosis Laterality Primary site Histology Behavior Grade Dates and types of all treatments

Picturing this???

It’s not the amount of text… it’s how you use it! Be concise- quality is more important than quantity Only document what’s relevant to the site/disease Use abbreviations

Abbreviations!!! Use ‘em….. Use accepted abbreviations from the Abstractor’s Manual available at help/cpdms.htm Appendix I (Common Acceptable Abbreviations)

….But Use Caution! Make sure your abbreviations aren’t confusing Spell out, at least once, any abbreviation that might not be easily recognized Use abbreviations in context

In addition to abbreviations, using symbols is also acceptable., =, & + (positive), x (times) 2/7 (two of seven)

You can omit vowels or use apostrophes to shorten words. Glsn (Gleason), Blm-Rch (Bloom-Richardson) Rec’d, dx’d

Match the abbreviations! Abdomen Bilateral Bone Marrow Anterior ANT BX ABD BIL Biopsy BM

Health and Physical: Demographics Name(s) Social Security Number Age….and DOB added is nice Sex Race Ethnicity Birth place

History and Physical Any previous cancer dx? When? Where? Describe the symptoms leading to the current admission (inpt or outpt) for dx and/or tx Remember to focus text on the cancer being dx’d and/or tx’d at this time

History and Physical Was this cancer dx’d at your facility or a different one? – Where? (give the facility, office, etc.) – Give the date, site and histology Has this cancer been previously treated? – Procedures, treatment, drugs, dose – Dates – Location End with your initials and the date

Example W/F, non-Hispanic with pelvic pain growing worse over the past 3 months. US at outside facility showed solid 10 cm mass rt ovary. Referred here for eval and tx. KDK 7/12/12

Imaging Include the date, scan type, and facility where performed Include only info relevant to the primary site – Any positive findings – Any negative findings that define stage Support your codes for CS Tumor Size, CS Extension, CS Lymph Nodes, CS Mets at Dx End with your initials and the date

Scopes Include the date, scope type, facility where performed, and the relevant findings End with your initials and the date

Lab Work Document tumor markers and site specific factors Document factors affecting prognosis or staging

Lab Work Include : Date of Test Facility Where Performed Result (value) Normal Range Your Initials with Date 11/21/12 UK: CEA 12.3 (nl < 5.0 ng/ml) KDK 4/13/13

Operative Findings Include the date, name of procedure, facility where performed, relevant findings and may also include – Organs removed – Any differences between intended procedure and actual procedure – Important site, size or staging info End with your initials and the date

Pathology Include the date, tissue taken, report number, facility where performed, site tissue was taken from, final diagnosis Include results regarding size, location, histology, grade, extension, LNs Comments and addenda are important and should also be included End with your initials and the date

Site Document the primary site (topography) as described in the medical record Document laterality End with your initials and the date

Histology Document the date and source of tissue Support your code for the primary tumor type – Include the final dx from cyto, path or clinical assessment Document behavior and grade End with your initials and the date

Staging Document TNM staging and who staged the patient Document whether there is clinical and/or pathologic staging For Collaborative Stage, show the original measurements and include the sources Include any info for Site Specific Factors if not covered elsewhere End with your initials and the date

Other Include info for : – Date of Dx, if not covered in earlier text – Class of case – Therapy planned and/or received including type, volume, modality – Following physicians – Follow-up info sources Follow-up info will typically be added here each year…along with your initials and the date

Reabstracting Audits! Are often performed using text information only….data not documented will be counted as errors.

Conflicting Info What if you follow the rules and your staging doesn’t match the physician staging? Code according to the rules and document how you arrived at your code (i.e. support your coding with text)

Follow-Up Systematic process of obtaining accurate information, at least annually, on the patient’s health, vital status, and progression of disease

Follow-Up Can assist in the early identification of recurrence Assists physician’s in getting former cancer patients to return for treatment or checkups Encourages periodic examination of cancer patients since they are prone to develop other cancers One very, very important word…..survival

Follow-Up Rules Follow-up info necessary for analytic cases only, with the following exceptions Patients who are currently residing in foreign countries e Patients whose only malignancy is carcinoma in situ of the cervix

The College (aka ACoS) Follow-up is considered delinquent by ACoS if info is not obtained and documented within 15 months of the patient’s previous date of last contact For an approved program, a follow-up rate of 90% of a hospital’s analytic cases in the past 5 years is needed to be in compliance

Follow-Up with KCR Current follow-up must be reported to KCR for every case dx’d since 1995 that is class Considered current if Date of Last Contact is within 15 months of current date CPDMS.net can create a report for patients needing updated follow-up

Word To The Wise….. Always maintain the highest follow-up rate possible! Falling behind is trouble that’s easy to get into….and hard to get out of

What To Collect Date of Last Contact Survival status Current address Disease status Recurrence info Additional treatment received Cause of death, if deceased Method of obtaining follow-up

A Few Words About Treatment Obtaining complete first course treatment info is extremely important Follow your registry rules, but a brief documentation (date, type, drug(s), start & stop dates) in the treatment notes section is ideal

Questions? Thanks to Kim Kimbler for her creative efforts in developing this power point presentation !